Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation.[
The report details the trend, potential and market size of Anaplastic Lymphoma Kinase Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anaplastic Lymphoma Kinase Inhibitorsmarket, defines the market attractiveness level of Anaplastic Lymphoma Kinase Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anaplastic Lymphoma Kinase Inhibitors industry, describes the types of Anaplastic Lymphoma Kinase Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anaplastic Lymphoma Kinase Inhibitors market and the development prospects and opportunities of Anaplastic Lymphoma Kinase Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anaplastic Lymphoma Kinase Inhibitors market in Chapter 13.
By Player:
Novartis AG
Tesaro, Inc
Crtierium, Inc
FHoffman-La Roche Ltd
Pfizer, Inc
Xcovery Holding Company, LLC
Betta Pharmaceutcials Co, Ltd
Oncoethix GmbH
Helsinn Therapeutics
Takeda Pharmaceutical Co, Ltd
By Type:
Crizotinib
Ceritinib
Alectinib Hydrochloride
By End-User:
NSCLC
Breast Cancer
Colorectal Cancer
Neuroblastoma
Ovarian Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anaplastic Lymphoma Kinase Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anaplastic Lymphoma Kinase Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anaplastic Lymphoma Kinase Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anaplastic Lymphoma Kinase Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anaplastic Lymphoma Kinase Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.2 United States Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.3 Europe Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.4 China Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.5 Japan Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.6 India Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
-
7.7 South Korea Anaplastic Lymphoma Kinase Inhibitors Consumption (2017-2022)
8 Region and Country-wise Anaplastic Lymphoma Kinase Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast (2022-2028)
9 Global Anaplastic Lymphoma Kinase Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Crizotinib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ceritinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Alectinib Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.2 Global Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Neuroblastoma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anaplastic Lymphoma Kinase Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Crizotinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ceritinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Alectinib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anaplastic Lymphoma Kinase Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anaplastic Lymphoma Kinase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anaplastic Lymphoma Kinase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anaplastic Lymphoma Kinase Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anaplastic Lymphoma Kinase Inhibitors Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.2 Tesaro, Inc
-
14.2.1 Tesaro, Inc Company Details
-
14.2.2 Tesaro, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tesaro, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.3 Crtierium, Inc
-
14.3.1 Crtierium, Inc Company Details
-
14.3.2 Crtierium, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Crtierium, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.4 FHoffman-La Roche Ltd
-
14.4.1 FHoffman-La Roche Ltd Company Details
-
14.4.2 FHoffman-La Roche Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 FHoffman-La Roche Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.5 Pfizer, Inc
-
14.5.1 Pfizer, Inc Company Details
-
14.5.2 Pfizer, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.6 Xcovery Holding Company, LLC
-
14.6.1 Xcovery Holding Company, LLC Company Details
-
14.6.2 Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.7 Betta Pharmaceutcials Co, Ltd
-
14.7.1 Betta Pharmaceutcials Co, Ltd Company Details
-
14.7.2 Betta Pharmaceutcials Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Betta Pharmaceutcials Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.8 Oncoethix GmbH
-
14.8.1 Oncoethix GmbH Company Details
-
14.8.2 Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.9 Helsinn Therapeutics
-
14.9.1 Helsinn Therapeutics Company Details
-
14.9.2 Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
14.10 Takeda Pharmaceutical Co, Ltd
-
14.10.1 Takeda Pharmaceutical Co, Ltd Company Details
-
14.10.2 Takeda Pharmaceutical Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Takeda Pharmaceutical Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anaplastic Lymphoma Kinase Inhibitors
-
Figure Anaplastic Lymphoma Kinase Inhibitors Picture
-
Table Global Anaplastic Lymphoma Kinase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anaplastic Lymphoma Kinase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anaplastic Lymphoma Kinase Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anaplastic Lymphoma Kinase Inhibitors Consumption by Country (2017-2022)
-
Figure United States Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anaplastic Lymphoma Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anaplastic Lymphoma Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crizotinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ceritinib Consumption and Growth Rate (2017-2022)
-
Figure Global Alectinib Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroblastoma Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Crizotinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ceritinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alectinib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anaplastic Lymphoma Kinase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anaplastic Lymphoma Kinase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Tesaro, Inc (Foundation Year, Company Profile and etc.)
-
Table Tesaro, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Crtierium, Inc (Foundation Year, Company Profile and etc.)
-
Table Crtierium, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crtierium, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table FHoffman-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table FHoffman-La Roche Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table FHoffman-La Roche Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Xcovery Holding Company, LLC (Foundation Year, Company Profile and etc.)
-
Table Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Betta Pharmaceutcials Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Betta Pharmaceutcials Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Betta Pharmaceutcials Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Oncoethix GmbH (Foundation Year, Company Profile and etc.)
-
Table Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Helsinn Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
Table Takeda Pharmaceutical Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Co, Ltd Anaplastic Lymphoma Kinase Inhibitors Product and Service
-
